<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04650139</url>
  </required_header>
  <id_info>
    <org_study_id>0925-0586</org_study_id>
    <nct_id>NCT04650139</nct_id>
  </id_info>
  <brief_title>Coronary Interventions Ulm - Coronary Chronic Total Occlusions</brief_title>
  <acronym>CSI</acronym>
  <official_title>Coronary Interventions Ulm - Coronary Chronic Total Occlusions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the proposed project is to provide the long-term results after a recanalization&#xD;
      attempt of chronically occluded coronary arteries.&#xD;
&#xD;
      To investigate recanalization attempt of chronically occluded coronary arteries at the Ulm&#xD;
      University Hospital. As shown, it is known that successful recanalization of a chronic&#xD;
      occlusion is associated with a lower event rate (reduced mortality and the need for operative&#xD;
      myocardial revascularization) compared to unsuccessful recanalization (drug therapy). The&#xD;
      standard in the therapy of successfully recanalized chronic occlusions is the use of&#xD;
      drug-releasing vascular supports.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>1 year</time_frame>
    <description>major adverse cardiac event</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TLR</measure>
    <time_frame>1 year</time_frame>
    <description>target lesion revascularization</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Chronic Total Occlusion of Coronary Artery</condition>
  <condition>Chronic Total Occlusion</condition>
  <arm_group>
    <arm_group_label>successful CTO</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non- successful CTO</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI - percutaneous coronary intervention</intervention_name>
    <description>percutaneous coronary intervention</description>
    <arm_group_label>non- successful CTO</arm_group_label>
    <arm_group_label>successful CTO</arm_group_label>
    <other_name>drug eluting stents, Scaffolds, drug eluting ballons</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with CTO&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years&#xD;
&#xD;
        Coronary intervention in chronic coronary artery occlusion&#xD;
&#xD;
        Occlusion &gt; 3 months&#xD;
&#xD;
        Indication for PTCA or recanalization according to guidlines&#xD;
&#xD;
        such as:&#xD;
&#xD;
        Symptoms of the patient&#xD;
&#xD;
        Evidence of myocardial ischemia (stress ECG, scintigraphic&#xD;
&#xD;
        Methods, magnetic resonance imaging, stress echocardiography)&#xD;
&#xD;
        pathological intracoronary flow reserve, prognostic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No chronic occlusion,&#xD;
&#xD;
          -  Contraindication to anti-platelet therapy&#xD;
&#xD;
        Acetylsalicylic acid plus clopidogrel for at least 3 months such as e.g.&#xD;
&#xD;
        with florid gastrointestinal ulcer disease,&#xD;
&#xD;
        History of hemorrhagic stroke&#xD;
&#xD;
        or urgent non-postponable surgical intervention.&#xD;
&#xD;
        Basic disease with a life expectancy of less than 12 months (here as a rule&#xD;
&#xD;
        no indication for PTCA or reopening available)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Correia</last_name>
      <phone>+4973145058</phone>
      <email>bruno.correia@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 24, 2020</study_first_submitted>
  <study_first_submitted_qc>November 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2020</study_first_posted>
  <last_update_submitted>November 24, 2020</last_update_submitted>
  <last_update_submitted_qc>November 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Ulm</investigator_affiliation>
    <investigator_full_name>Bruno Correia</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

